GE HealthCare Technologies Management
Management criteria checks 0/4
GE HealthCare Technologies' CEO is Pete Arduini, appointed in Dec 2022, has a tenure of 1.92 years. total yearly compensation is $24.51M, comprised of 5.1% salary and 94.9% bonuses, including company stock and options. directly owns 0.003% of the company’s shares, worth $1.02M. The average tenure of the management team and the board of directors is 1.9 years and 1.9 years respectively.
Key information
Pete Arduini
Chief executive officer
US$24.5m
Total compensation
| CEO salary percentage | 5.1% |
| CEO tenure | 2yrs |
| CEO ownership | 0.003% |
| Management average tenure | 1.9yrs |
| Board average tenure | 1.9yrs |
Recent management updates
Recent updates
2025 Could Be GE HealthCare's Year With Emphasis On Efficiency And AI Broadens
Dec 19With GE HealthCare Technologies Inc. (NASDAQ:GEHC) It Looks Like You'll Get What You Pay For
Dec 16
GE HealthCare: Growth Acceleration In 2025 Can Drive Stock Higher
Dec 06From Spin-Off To Standout: GE HealthCare Is Pretty Impressive
Oct 30GE HealthCare: The Image Of More Upside Is Very Real
Sep 18Are Investors Undervaluing GE HealthCare Technologies Inc. (NASDAQ:GEHC) By 28%?
Sep 05GE HealthCare Q2 Earnings Recap (Rating Downgrade)
Aug 06GE HealthCare: Near-Term Risks, But Some Interesting Longer-Term Opportunities
Jul 07Is GE HealthCare Technologies (NASDAQ:GEHC) A Risky Investment?
May 21GE HealthCare: Too Soon To Buy After A Mixed Q1 (Rating Downgrade)
May 02GE HealthCare Technologies Inc.'s (NASDAQ:GEHC) Intrinsic Value Is Potentially 100% Above Its Share Price
Apr 25GE Vernova: An Interesting Stalwart To Ride The Energy Transition
Apr 02GE HealthCare Technologies: Growth Prospects Remain Encouraging, And Valuation Is Attractive
Mar 25GE HealthCare Technologies' Roar Higher Isn't Over Yet
Mar 09CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Sep 30 2024 | n/a | n/a | US$2b |
| Jun 30 2024 | n/a | n/a | US$2b |
| Mar 31 2024 | n/a | n/a | US$2b |
| Dec 31 2023 | US$25m | US$1m | US$1b |
| Sep 30 2023 | n/a | n/a | US$2b |
| Jun 30 2023 | n/a | n/a | US$2b |
| Mar 31 2023 | n/a | n/a | US$2b |
| Dec 31 2022 | US$10m | US$1m | US$2b |
Compensation vs Market: Pete's total compensation ($USD24.51M) is above average for companies of similar size in the US market ($USD12.88M).
Compensation vs Earnings: Pete's compensation has increased by more than 20% in the past year.
CEO
Pete Arduini (59 yo)
2yrs
Tenure
US$24,510,947
Compensation
Mr. Peter J. Arduini, also known as Pete, serves as Director of Ge Healthcare since January 2023. He was a Senior Vice President at General Electric Company since January 2022. He has been President and Ch...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| President | 2yrs | US$24.51m | 0.0028% $ 1.0m | |
| VP & CFO | 1.5yrs | US$10.97m | 0.0033% $ 1.2m | |
| Chief Science & Technology Officer | 1.9yrs | US$13.87m | 0.0035% $ 1.3m | |
| VP, General Counsel & Corporate Secretary | 1.9yrs | US$7.51m | 0.0047% $ 1.7m | |
| Controller & Chief Accounting Officer | 2yrs | no data | 0.0012% $ 418.2k | |
| Chief Information Officer | no data | no data | no data | |
| Chief Investor Relations Officer | no data | no data | no data | |
| Chief Corporate Marketing & Communications Officer | no data | no data | no data | |
| Chief People Officer | less than a year | no data | no data | |
| President & CEO of Patient Care Solutions | 4.9yrs | no data | 0.0014% $ 490.3k | |
| President & CEO of Pharmaceutical Diagnostics | no data | no data | 0.0020% $ 717.4k | |
| President & CEO of Imaging | 1.9yrs | no data | 0.0053% $ 1.9m |
1.9yrs
Average Tenure
55yo
Average Age
Experienced Management: GEHC's management team is not considered experienced ( 1.9 years average tenure), which suggests a new team.
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| President | 1.9yrs | US$24.51m | 0.0028% $ 1.0m | |
| Chairman | 1.9yrs | US$531.65k | 0.089% $ 31.9m | |
| Lead Independent Director | 1.9yrs | US$456.65k | 0.00023% $ 82.9k | |
| Independent Director | 1.9yrs | US$401.61k | 0% $ 0 | |
| Independent Director | 1.9yrs | US$421.58k | 0% $ 0 | |
| Independent Director | 1.9yrs | US$401.61k | 0% $ 0 | |
| Independent Director | 1.9yrs | US$401.65k | 0% $ 0 | |
| Independent Director | 1.9yrs | US$401.65k | 0% $ 0 | |
| Independent Director | 1.9yrs | US$401.65k | 0% $ 0 | |
| Independent Director | 2yrs | US$426.65k | 0% $ 0 |
1.9yrs
Average Tenure
60.5yo
Average Age
Experienced Board: GEHC's board of directors are not considered experienced ( 1.9 years average tenure), which suggests a new board.
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/22 02:05 |
| End of Day Share Price | 2024/12/20 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
GE HealthCare Technologies Inc. is covered by 27 analysts. 19 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Navann Ty Dietschi | BNP Paribas Exane |
| Craig Bijou | BofA Global Research |
| Michael Gorman | BTIG |